Vol 3, No 3 (1999)
Prace oryginalne
Published online: 2000-03-09
Get Citation

Angiotensin Converting Enzyme

Jerzy Bellwon, Marcin Gruchała, Janusz Siebert, Bartosz Wasąg, Karolina Ochman, Radosław Targoński, Dariusz Ciećwierz, Janusz Limon, Andrzej Rynkiewicz
Nadciśnienie tętnicze 1999;3(3):173-181.
Vol 3, No 3 (1999)
Prace oryginalne
Published online: 2000-03-09

Abstract


Background The renin-angiotensin-aldosteron system plays important role in the patogenesis of the cardiovascular diseases. The aim of our study was to assess angiotensin converting enzyme gene (ACE gene) polymorphic variants in subjects without clinical manifestations of atherosclerotic diseases. 'The ACE gene polymorphism distribution was compared with blood preassure and other risk factors of atherosclerosis distribution.
Material and metod We examined 307 subjects, 254 men and 53 women, mean age 44 ± 9 years, who did not have any symptoms of coronary artery disease, stroke or other cardiovascular diseases. We measured blood preassure, weight, height, weist and hip circumference, serum glucose and lipids levels. In each subject ecg was performed. The polymerase chain reaction and agarose gel electrophoresis were used to determine the ACE I/D genotype.
Results There was no significant difference in the genotype distribution and allel frequency between subjects with normal (DD - 34%, ID - 40% i II - 26°l0, allel D - 54%, allel I - 46%) and high blood pressure (DD - 39%, ID - 36% i II - 25%, allel D - 57%, allel I - 43%). Distribution of common atherosclerosis risk factors was independent from ACE gene IJD polymorphism. There was also no significant difference in the genotype distribution and allel frequency between subjects with low (< 5%) and high (> 20%) risk of coronary event.
Conclusions It seems that the presence of a particularACE gene polymorphic variant has no significant influence on blood pressure level and other studied risk factor of atherosclerosis.

Abstract


Background The renin-angiotensin-aldosteron system plays important role in the patogenesis of the cardiovascular diseases. The aim of our study was to assess angiotensin converting enzyme gene (ACE gene) polymorphic variants in subjects without clinical manifestations of atherosclerotic diseases. 'The ACE gene polymorphism distribution was compared with blood preassure and other risk factors of atherosclerosis distribution.
Material and metod We examined 307 subjects, 254 men and 53 women, mean age 44 ± 9 years, who did not have any symptoms of coronary artery disease, stroke or other cardiovascular diseases. We measured blood preassure, weight, height, weist and hip circumference, serum glucose and lipids levels. In each subject ecg was performed. The polymerase chain reaction and agarose gel electrophoresis were used to determine the ACE I/D genotype.
Results There was no significant difference in the genotype distribution and allel frequency between subjects with normal (DD - 34%, ID - 40% i II - 26°l0, allel D - 54%, allel I - 46%) and high blood pressure (DD - 39%, ID - 36% i II - 25%, allel D - 57%, allel I - 43%). Distribution of common atherosclerosis risk factors was independent from ACE gene IJD polymorphism. There was also no significant difference in the genotype distribution and allel frequency between subjects with low (< 5%) and high (> 20%) risk of coronary event.
Conclusions It seems that the presence of a particularACE gene polymorphic variant has no significant influence on blood pressure level and other studied risk factor of atherosclerosis.
Get Citation

Keywords

I/D ACE gene polymorphisn arterial hypertension; risk factors of atherosclerosis

About this article
Title

Angiotensin Converting Enzyme

Journal

Arterial Hypertension

Issue

Vol 3, No 3 (1999)

Pages

173-181

Published online

2000-03-09

Bibliographic record

Nadciśnienie tętnicze 1999;3(3):173-181.

Keywords

I/D ACE gene polymorphisn arterial hypertension
risk factors of atherosclerosis

Authors

Jerzy Bellwon
Marcin Gruchała
Janusz Siebert
Bartosz Wasąg
Karolina Ochman
Radosław Targoński
Dariusz Ciećwierz
Janusz Limon
Andrzej Rynkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl